Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Department

Conference Insider
Patients Taking Haegarda Used Less On-Demand Therapy, Reduce Plan Spending
05/31/2018
A poster presented at the AMCP 2018 Annual Meeting showed that patients with hereditary angioedema who received Haegarda (C1 esterase inhibitor subcutaneous; CSL Behring) took less on-demand therapy during prophylactic treatment.
A poster presented at the AMCP 2018 Annual Meeting showed that patients with hereditary angioedema who received Haegarda (C1 esterase inhibitor subcutaneous; CSL Behring) took less on-demand therapy during prophylactic treatment.
A poster presented at the AMCP...
05/31/2018
First Report Managed Care
Conference Insider
Diabetes Patients With Multiple Daily Injections Have Low Persistence, High Medical Costs
05/31/2018
An award-winning poster at the AMCP 2018 Annual Meeting found that type 2 diabetes patients who need multiple daily injections of basal-bosul insulin have low 1-year persistence and higher medial costs
An award-winning poster at the AMCP 2018 Annual Meeting found that type 2 diabetes patients who need multiple daily injections of basal-bosul insulin have low 1-year persistence and higher medial costs
An award-winning poster at the...
05/31/2018
First Report Managed Care

Advertisement

Conference Insider
Pharma Trends in 2018: Generic Drugs in “Race to the Bottom,” Biosimilars Fail to Launch, Market Access Faces Challenges
05/31/2018
During his presentation at the AMCP 2018 Annual Meeting, “2017-2018 Pharmaceutical Marketplace Trends,” Douglas Long, BS, MBA, vice president of Industry Relations at IQVIA, outlined the market trends impacting the pharmaceutical...
During his presentation at the AMCP 2018 Annual Meeting, “2017-2018 Pharmaceutical Marketplace Trends,” Douglas Long, BS, MBA, vice president of Industry Relations at IQVIA, outlined the market trends impacting the pharmaceutical...
During his presentation at the...
05/31/2018
First Report Managed Care
Conference Insider
Payers Say HCEI Sharing Needs Improvement Despite 21st Cures Act Implementation
05/31/2018
A study at the AMCP 2018 Annual Meeting surveyed payer experiences sharing health care economics information (HCEI) after passage of the 21st Century Cures Act and highlighted areas for improvement. 
A study at the AMCP 2018 Annual Meeting surveyed payer experiences sharing health care economics information (HCEI) after passage of the 21st Century Cures Act and highlighted areas for improvement. 
A study at the AMCP 2018 Annual...
05/31/2018
First Report Managed Care
Conference Insider
Navigating the Emerging Challenges of Gene Therapy
05/31/2018
During a session at the AMCP 2018 Annual Meeting, Nicole Trask, PharmD, clinical consultant pharmacist at the University of Massachusetts, discussed the challenges payers will face as gene therapies gain popularity and feasibility across a...
During a session at the AMCP 2018 Annual Meeting, Nicole Trask, PharmD, clinical consultant pharmacist at the University of Massachusetts, discussed the challenges payers will face as gene therapies gain popularity and feasibility across a...
During a session at the AMCP...
05/31/2018
First Report Managed Care

Advertisement

Conference Insider
Study Examines Multiple PARP Inhibitors
05/07/2018
A featured poster session at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated...
A featured poster session at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated...
A featured poster session at the...
05/07/2018
First Report Managed Care
Conference Insider
The Current and Future Role of PARP Inhibitors
05/07/2018
Joyce F Liu, MD, MPH, recently discussed the current and future role of PARP inhibitors for the treatment of ovarian cancer at the Society of Gynecologic Oncology’s 2018 Annual Meeting.
Joyce F Liu, MD, MPH, recently discussed the current and future role of PARP inhibitors for the treatment of ovarian cancer at the Society of Gynecologic Oncology’s 2018 Annual Meeting.
Joyce F Liu, MD, MPH, recently...
05/07/2018
First Report Managed Care
Conference Insider
ASCO Alternative Payment Model Yields Savings in Ovarian Cancer
05/07/2018
The American Society of Clinical Oncology’s (ASCO) Patient-Centered Oncology Payment (PCOP) model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period, according to a study...
The American Society of Clinical Oncology’s (ASCO) Patient-Centered Oncology Payment (PCOP) model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period, according to a study...
The American Society of Clinical...
05/07/2018
First Report Managed Care

Advertisement

Conference Insider
Urgent TAVR Has Beneficial Outcomes Compared With Elective TAVR
05/07/2018
Recent research presented at the ACC 2018 Scientific Session found that urgent or emergent transcatheter aortic valve replacement (TAVR) has acceptable outcomes when compared with elective TAVR. 
Recent research presented at the ACC 2018 Scientific Session found that urgent or emergent transcatheter aortic valve replacement (TAVR) has acceptable outcomes when compared with elective TAVR. 
Recent research presented at the...
05/07/2018
First Report Managed Care
Conference Insider
P2Y12 Inhibitor Copayment Program Did Not Improve Outcomes for MI Patients
05/07/2018
A recent clinical trial found that while reducing copayments for myocardial infarction (MI) patients taking P2Y12 receptor inhibitors improved adherence, it did not impact clinical outcomes after 1 year.
A recent clinical trial found that while reducing copayments for myocardial infarction (MI) patients taking P2Y12 receptor inhibitors improved adherence, it did not impact clinical outcomes after 1 year.
A recent clinical trial found...
05/07/2018
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Without Reforms, U.S. Retirees to Face Dwindling Funds
04/24/2012
04/24/2012
First Report Managed Care
News
AbbVie Forges Deeper into Cancer, As Clock Ticks for Humira
04/29/2016
AbbVie Inc placed another big bet on new cancer drugs on Thursday with a $5.8 billion acquisition that could lessen its dependence on arthritis treatment Humira, the world's top selling drug.
AbbVie Inc placed another big bet on new cancer drugs on Thursday with a $5.8 billion acquisition that could lessen its dependence on arthritis treatment Humira, the world's top selling drug.
AbbVie Inc placed another big...
04/29/2016
First Report Managed Care
Feature
Preventing Conversion to Diabetes from Impaired Glucose Tolerance
07/18/2011
Twenty-one million Americans are affected by type 2 diabetes mellitus, and the prevalence of the disease is increasing. Type 2 diabetes begins with a genetic predisposition and progresses from normal glucose tolerance with insulin resistance...
Twenty-one million Americans are affected by type 2 diabetes mellitus, and the prevalence of the disease is increasing. Type 2 diabetes begins with a genetic predisposition and progresses from normal glucose tolerance with insulin resistance...
Twenty-one million Americans are...
07/18/2011
First Report Managed Care
News
States put their own spin on Obama health care law
03/16/2011
03/16/2011
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use